News Image

Thursday's session: top gainers and losers

By Mill Chart

Last update: Sep 22, 2022

Let's have a look at the top gainers and losers one hour before the close of the markets of today's session.

Top gainers

TickerChangeComment
SPRO168.0%SPERO THERAPEUTICS INC's (NASDAQ:SPRO) stock price is advancing with 168.0% to a price of $2.2. In the last 6 months the share price dropped with 89.92%.
BOA.W105.0%BOA ACQUISITION CL A -CW28 (NYSE:BOA.W) rose 105.0% to $0.14 during Thursday's after hours session. Shareholders saw the stock price going 65.5% lower in the past 3 months.
ATXI92.33%AVENUE THERAPEUTICS INC's (NASDAQ:ATXI) stock price is advancing with 92.33% to a price of $0.41. The stock is trading 65.23% lower than 6 months ago.
AVCT48.35%AMERICAN VIRTUAL CLOUD TECHN's (NASDAQ:AVCT) stock price is advancing with 48.35% to a price of $0.32. The stock is trading 53.27% higher than a month ago.
AVCTW46.4%PENSARE ACQUISITION CORP-CW's (NASDAQ:AVCTW) stock price is advancing with 46.4% to a price of $0.07. In the last 3 months the share price increased with 30.59%.
SAVA29.12%CASSAVA SCIENCES INC's (NASDAQ:SAVA) stock price increased by 29.12% to $48.6. In the last month the stock gained 48.72%.
SONN28.79%SONNET BIOTHERAPEUTICS HOLDI's (NASDAQ:SONN) stock price increased by 28.79% to $1.7. In the last month the stock lost 60.53%.
GSMGW26.42%GLORY STAR NEW -CW25's (NASDAQ:GSMGW) stock price increased by 26.42% to $0.02. In the last 3 months the share price increased with 78.65%.
BEAT24.68%HEARTBEAM INC's (NASDAQ:BEAT) shares rose 24.68% to $1.97 during Thursday's session. The stock is trading 20.61% higher than a month ago.
PIXY22.18%SHIFTPIXY INC's (NASDAQ:PIXY) stock price increased by 22.18% to $16.69. Shareholders saw the stock price going 41.32% lower in the past month.

For the full top gainers list go to our top gainers screener.

Losers

TickerChangeComment
MOHO-46.79%ECMOHO LTD's (NASDAQ:MOHO) shares fell 46.79% to $0.09 during Thursday's session. The stock is trading 31.61% lower than 6 months ago.
TOPS-23.9%TOP SHIPS INC's (NASDAQ:TOPS) stock price decreased by 23.9% to $0.16. Shareholders saw the stock price going 29.7% lower in the past month.
SOBR-23.43%SOBR SAFE INC's (NASDAQ:SOBR) stock price is declining with 23.43% to a price of $1.83. In the last month the share price increased with 115.0%.
OPP--23.08%River North Dble Line Strtgc Opp Fd [Opp/I/R]'s (NYSE:OPP-) shares fell 23.08% to $0.0. In the last month the share price dropped with 97.61%.
AYLA-20.0%AYALA PHARMACEUTICALS INC's (NASDAQ:AYLA) stock price is declining with 20.0% to a price of $0.88. In the last 6 months the share price dropped with 73.24%.
CPTN-19.38%CEPTON INC's (NASDAQ:CPTN) shares fell 19.38% to $1.69 during Thursday's session. A press release (Cepton Adds Lidar Digital Twin to NVIDIA DRIVE Sim, Advancing the Development of Safe Autonomous Driving Technology) was released yesterday.
LAZR-18.79%LUMINAR TECHNOLOGIES INC's (NASDAQ:LAZR) shares fell 18.79% to $7.61. In the last 3 months the share price increased with 25.1%.
AGRI-18.64%AGRIFORCE GROWING SYSTEMS LT's (NASDAQ:AGRI) stock price is declining with 18.64% to a price of $1.44. Shareholders saw the stock price going 29.2% lower in the past 3 months.
HSDT-18.41%HELIUS MEDICAL TECHNOLOGIES's (NASDAQ:HSDT) shares fell 18.41% to $0.36. In the last month the share price dropped with 38.41%.
JCSE-16.67%JE CLEANTECH HOLDINGS LTD's (NASDAQ:JCSE) shares fell 16.67% to $0.95 during Thursday's session. The stock is trading 40.93% lower than a month ago.

Our top losers screener will show you the full list.

Back

SPERO THERAPEUTICS INC

NASDAQ:SPRO (4/24/2024, 4:35:37 PM)

1.42

-0.02 (-1.05%)

SPRO News

News Imagea month ago - InvestorPlaceToday’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

It's time to start the day with a breakdown of all the biggest pre-market stock movers worth watching on Thursday morning!

News Imagea month ago - Spero Therapeutics, Inc.Spero Therapeutics Announces Fourth Quarter and Full Year 2023 Operating Results and Provides a Business Update

On track for topline data from SPR720 Phase 2a proof-of-concept trial in treatment-naive and treatment-experienced non-refractory NTM-PD patients, expected...

News Image2 months ago - Spero Therapeutics, Inc.Spero Therapeutics to Provide Business Update and Report Fourth Quarter and Full Year 2023 Financial Results on Wednesday, March 13, 2024

CAMBRIDGE, Mass., March 06, 2024 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company,...

News Image2 months ago - Spero Therapeutics, Inc.Spero Therapeutics Announces Clearance of IND for SPR206 to Treat MDR Gram-negative Bacterial Infections

CAMBRIDGE, Mass., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company,...

News Image2 months ago - Spero Therapeutics, Inc.Spero Therapeutics to Present at Cowen’s 44th Annual Healthcare Conference

CAMBRIDGE, Mass., Feb. 26, 2024 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO) (Spero), a multi-asset clinical-stage biopharmaceutical...

News Image3 months ago - Spero Therapeutics, Inc.Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CAMBRIDGE, Mass., Jan. 31, 2024 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company,...

News Image4 months ago - Spero Therapeutics, Inc.Spero Therapeutics Provides Corporate Update and 2024 Outlook

In 2H 2024, expect to provide Phase 2a topline proof-of-concept data from our wholly-owned lead program SPR720 in NTM-PD patients

News Image4 months ago - Spero Therapeutics, Inc.Spero Therapeutics Announces First Patient, First Visit for Phase 3 PIVOT-PO Trial Evaluating Tebipenem HBr in Complicated Urinary Tract Infections

$95 million in development milestones payable over two years, as part of GSK license agreement...

News Image6 months ago - Bragar Eagel & Squire, P.C.SPERO ALERT: Bragar Eagel & Squire, P.C. is Investigating Spero Therapeutics, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
SPRO Links
Follow us for more